Skip to main content
. 2021 Apr 19;113(6):1411–1427. doi: 10.1093/ajcn/nqaa449

TABLE 4.

Strength and physical performance1

Change from PRE  Estimated between-group difference vs. CON at POST, mean (95% CI)
PRE MID2 POST2 P
Handgrip strength, kg
 CON3 31.7 ± 10.3 −0.1 ± 3.2 0.5 ± 3.5
 LEU-PRO4 30.3 ± 10.2 0.6 ± 2.9 1.0 ± 3.1 0.5 (−1.4, 2.3) 0.61
 LEU-PRO+n–35 27.3 ± 10.3 −0.2 ± 3.8 0.0 ± 3.3 −0.8 (−2.6, 1.0) 0.40
Isometric knee extension peak torque, Nm
 CON3 134.1 ± 44.9 0.3 ± 17.6 3.7 ± 17.9
 LEU-PRO4 126.7 ± 50.0 2.2 ± 23.7 8.7 ± 23.7 4.9 (−5.8, 15.5) 0.37
 LEU-PRO+n–36 125.4 ± 55.1 −2.0 ± 18.4 −1.1 ± 25.5 −6.5 (−16.8, 3.9) 0.22
Isokinetic knee extension peak torque at 60°/s, Nm
 CON3 91.8 ± 33.8 −1.6 ± 14.6 −2.6 ± 16.0
 LEU-PRO7 86.4 ± 31.1 −0.1 ± 13.0 −0.1 ± 18.2 2.4 (−5.3, 10.0) 0.55
 LEU-PRO+n–38 84.2 ± 40.3 0.1 ± 12.0 −2.6 ± 13.3  0.1 (−7.4, 7.5) 0.99
Isokinetic knee extension peak torque at 120°/s, Nm
 CON3 67.4 ± 24.8 −1.3 ± 11.0 1.9 ± 11.7
 LEU-PRO7 62.3 ± 25.7 −0.1 ± 15.1 −0.6 ± 13.4 −2.0 (−8.5, 4.6) 0.56
 LEU-PRO+n–38 63.8 ± 30.7 −3.0 ± 9.6 −2.2 ± 12.6 −3.2 (−9.6, 3.2) 0.32
Isometric knee flexion peak torque, Nm
 CON9 47.9 ± 17.2 0.8 ± 11.8 4.0 ± 9.3
 LEU-PRO10 48.0 ± 17.9 −0.5 ± 10.0 1.2 ± 10.1 −2.8 (−8.3, 2.8)0.320.32 0.32
 LEU-PRO+n–311 45.8 ± 22.0 −1.1 ± 8.7 −2.8 ± 11.6 −7.1 (−12.5, −1.8)  <0.01
SPPB score
 CON3 10.7 ± 1.6 0.3 ± 0.9 0.3 ± 0.9
 LEU-PRO12 11.1 ± 1.0 0.4 ± 1.2 −0.1 ± 1.4 −0.1 (−0.6, 0.4) 0.75
 LEU-PRO+n–36 10.7 ± 1.3 0.0 ± 1.3 −0.1 ± 1.1 −0.3 (−0.8, 0.2) 0.29
Gait speed, m/s
 CON13 0.76 ± 0.17 −0.02 ± 0.10 −0.04 ± 0.08
 LEU-PRO12 0.72 ± 0.12 0.00 ± 0.08 0.00 ± 0.10 0.03 (−0.02, 0.08) 0.25
 LEU-PRO+n–314 0.77 ± 0.17 0.00 ± 0.01 0.02 ± 0.11 0.04 (−0.01, 0.09) 0.08
FTSTS, s
 CON15 12.2 ± 2.3 −0.6 ± 2.0 −0.1 ± 1.8
 LEU-PRO16 11.6 ± 2.6 −0.2 ± 2.4 0.7 ± 2.8 0.7 (−0.5, 1.9) 0.25
 LEU-PRO+n–317 12.2 ± 3.1 −0.2 ± 2.4 1.1 ± 2.5 1.0 (−0.2, 2.2) 0.09
TUG, s
 CON18 7.0 ± 1.3 0.0 ± 0.8 0.0 ± 0.8
 LEU-PRO4 6.7 ± 1.0 0.2 ± 0.8 0.3 ± 1.0 0.3 (−0.2, 0.7) 0.27
 LEU-PRO+n–319 7.0 ± 1.4 0.2 ± 1.1 0.3 ± 0.9 0.2 (−0.3, 0.6) 0.42
Single-leg standing balance, s
 CON20 26.3 ± 23.6 2.0 ± 13.1 0.8 ± 13.6
 LEU-PRO4 26.2 ± 19.1 7.6 ± 16.8 3.1 ± 15.7 1.5 (−6.5, 9.5) 0.71
 LEU-PRO+n–321 28.0 ± 21.5 8.2 ± 17.4 6.5 ± 16.1 4.4 (−3.5, 12.3) 0.27
1

PRE value, change from PRE-to-MID and change from PRE-to-POST values are means ± SDs. Data represent the total cohort and were analyzed by an intention-to-treat approach using a linear mixed model with group (CON, LEU-PRO, LEU-PRO+n–3), time (MID, POST) and the group-by-time interaction as fixed factors; participants as a random factor; and PRE value as a covariate. Estimated between-group differences represent LEU-PRO − CON and LEU-PRO+n–3 − CON at POST and are derived from the linear mixed model and adjusted for PRE value. CON, control; FTSTS, 5 times sit-to-stand; LEU-PRO, leucine-enriched protein; LEU-PRO+n–3, leucine-enriched protein plus long-chain n–3 PUFAs; MID, mid-intervention; POST, postintervention; PRE, preintervention; SPPB, Short Physical Performance Battery; TUG, Timed Up-and-Go.

2

PRE-to-MID changes represent participants with both PRE and MID data, PRE-to-POST changes represent participants with both PRE and POST data.

3

PRE n = 31, MID n = 28, POST n = 25.

4

PRE n = 36, MID n = 28, POST n = 28.

5

PRE n = 36, MID n = 32, POST n = 30.

6

PRE n = 36, MID n = 33, POST n = 31.

7

PRE n = 36, MID n = 28, POST n = 27.

8

PRE n = 36, MID n = 33, POST n = 30.

9

PRE n = 29, MID n = 27, POST n = 24.

10

PRE n = 35, MID n = 28, POST n = 28.

11

PRE n = 36, MID n = 32, POST n = 31.

12

PRE n = 36, MID n = 29, POST n = 28.

13

PRE n = 30, MID n = 26, POST n = 24.

14

PRE n = 36, MID n = 29, POST n = 31.

15

PRE n = 30, MID n = 26, POST n = 23.

16

PRE n = 35, MID n = 29, POST n = 28.

17

PRE n = 35, MID n = 28, POST n = 31.

18

PRE n = 30, MID n = 27, POST n = 24.

19

PRE n = 35, MID n = 31, POST n = 31.

20

PRE n = 30, MID n = 27, POST n = 34.

21

PRE n = 36, MID n = 31, POST n = 30.